Biotech firms weigh up listings and takeovers amid fierce demand
Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline
Available in your choice of English or Arabic
Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline
The round saw participation from Kingdom’s Qomel Company, US-based NantBio, and US93
Queue